Correlation Between Mesoblast and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mesoblast and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mesoblast and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mesoblast and Effector Therapeutics, you can compare the effects of market volatilities on Mesoblast and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mesoblast with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mesoblast and Effector Therapeutics.
Diversification Opportunities for Mesoblast and Effector Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mesoblast and Effector is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Mesoblast and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Mesoblast is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mesoblast are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Mesoblast i.e., Mesoblast and Effector Therapeutics go up and down completely randomly.
Pair Corralation between Mesoblast and Effector Therapeutics
If you would invest 1,084 in Mesoblast on October 8, 2024 and sell it today you would earn a total of 928.00 from holding Mesoblast or generate 85.61% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 5.26% |
Values | Daily Returns |
Mesoblast vs. Effector Therapeutics
Performance |
Timeline |
Mesoblast |
Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Mesoblast and Effector Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mesoblast and Effector Therapeutics
The main advantage of trading using opposite Mesoblast and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mesoblast position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.Mesoblast vs. Aditxt Inc | Mesoblast vs. Lipocine | Mesoblast vs. Connect Biopharma Holdings | Mesoblast vs. Acumen Pharmaceuticals |
Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |